M. Maurer-Granofszky Et Al. , "An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report," CANCERS , vol.13, no.23, 2021
Maurer-Granofszky, M. Et Al. 2021. An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report. CANCERS , vol.13, no.23 .
Maurer-Granofszky, M., Schumich, A., Buldini, B., Gaipa, G., Kappelmayer, J., Mejstrikova, E., ... Karawajew, L.(2021). An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report. CANCERS , vol.13, no.23.
Maurer-Granofszky, Margarita Et Al. "An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report," CANCERS , vol.13, no.23, 2021
Maurer-Granofszky, Margarita Et Al. "An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report." CANCERS , vol.13, no.23, 2021
Maurer-Granofszky, M. Et Al. (2021) . "An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report." CANCERS , vol.13, no.23.
@article{article, author={Margarita Maurer-Granofszky Et Al. }, title={An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report}, journal={CANCERS}, year=2021}